Serpentine Ventures

What Serpentine Ventures does

Serpentine Ventures AG is a FINMA-licensed Swiss venture asset manager and the investment arm of Swiss Ventures Group AG. Founded in 2015 and headquartered in Zürich with a secondary presence in Stettlen bei Bern, the firm operates a multi-fund strategy spanning three vehicles: Rookie Fund I (pre-seed), Flagship Fund I (early-stage), and the Swiss Diabetes Venture Fund (thematic diabetes technology). Its geographic mandate covers Switzerland, Europe, Israel, and the United States, and the firm has funded more than 50 portfolio companies supporting over 650 jobs. Customers are qualified investors — high net worth individuals, professional investors, and institutional clients such as pension funds and family offices seeking regulated exposure to early-stage venture capital.

The firm's core product is regulated fund management delivered through a sales-led model combining direct relationships with qualified investors and bank-channel distribution via the strategic partnership with Redstone Global Ventures Portfolio (RGV), an ELTIF-structured fund of funds accessible through Swiss banks by ISIN. Serpentine is part of the wider Swiss Ventures Group ecosystem, which bundles venture intelligence (BV4), legal services (CodeLaw), and operational support (GetGoing) alongside the Swiss Startup Factory venture studio. Investment decisions leverage the SOFIA analytics platform via Redstone for data-driven due diligence across a population exceeding 180 portfolio companies.

Revenue is generated from two streams: recurring management fees charged on committed and deployed capital across the three funds, and lumpy carried interest on successful exits. The firm additionally invests in thought-leadership channels, including a joint executive education program with IMD business school launched in 2023 and an explicit ESG investment policy, both of which support LP pipeline development. Distribution relies on direct sales to qualified investors in Switzerland and channel partnerships (Redstone for bank distribution; IMD for executive education reach), with no publicly disclosed fund terms or fee schedules.

Name

Serpentine Ventures

Legal name

Serpentine Ventures AG

Website

https://serpentine.vc

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Serpentine Ventures AG is a FINMA-licensed Swiss venture asset manager operating three funds (Rookie Fund I, Flagship Fund I, Swiss Diabetes Venture Fund) that provide venture capital access to high net worth, professional, and institutional investors across Switzerland, Europe, Israel, and the US.

Ownership category

akta.pro rank

Product category

Venture Capital Asset Management

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

• Venture capital management
• Venture asset management
• Early-stage investment funds
• Startup venture funding
• Venture capital funds

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Technology or R&D, Marketing or Sales

Revenue model

1. Asset Management Fees: Revenue generated through management fees from operating venture capital funds including Rookie Fund I, Flagship Fund I, and Swiss Diabetes Venture Fund. Services target high net worth, professional and institutional clients.
2. Investment Returns / Carried Interest: Returns from successful portfolio company exits and investments through their venture capital funds, generating carried interest for the firm.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Serpentine Ventures AG is a FINMA-licensed Swiss venture asset manager that manages multiple specialized venture capital funds targeting different stages and themes. It operates three primary funds: Rookie Fund I (pre-seed technology ventures), Flagship Fund I (early-stage startups across Switzerland, Europe, Israel, US), and Swiss Diabetes Venture Fund (thematic diabetes technology investments). The firm provides venture capital access and ongoing portfolio support to professional and institutional investors.

Product overview

Serpentine Ventures operates as a FINMA licensed Swiss venture asset manager offering a multi-fund strategy covering the entire lifecycle of venture investments. The firm manages three distinct investment funds: Rookie Fund I (pre-seed investments), Flagship Fund I (early-stage investments), and Swiss Diabetes Venture Fund (thematic diabetes technology investments). These funds provide venture capital access to professional and institutional clients, targeting high-growth potential startups primarily in Switzerland, Europe, Israel, and the US.

Differentiator

Problem solved

Functional benefit

Brands

• Rookie Fund I: Super Angel fund investing in pre-seed technology ventures in Switzerland and beyond
• Flagship Fund I
• Swiss Diabetes Venture Fund

Products and services

• Rookie Fund I Super Angel fund investing in pre-seed technology ventures in Switzerland and beyond, for professional and institutional investors seeking early-stage venture exposure.
• Flagship Fund I Early-stage venture capital fund investing in high-growth potential startups across Switzerland, Europe, Israel, and the US. Targets professional and institutional clients.
• Swiss Diabetes Venture Fund Thematic venture capital fund investing in early-stage diabetes technology ventures across Switzerland, Europe, Israel, and the US.

Quantifiable outcome

• 50+ companies funded across portfolio
• +2 more outcomes

Named customers11 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core and flagship.

• RedstonecoreStrategic or Co-development Partner · 17 June 2025Strategic partnership to make the Redstone Global Ventures Portfolio (RGV) accessible to qualified Swiss investors. RGV offers exposure to 250+ startups through sector-specific funds including Serpentine's Diabetes Ventures Fund. Target sectors include FinTech, Health, Industrial Tech, Deep Tech, AI, Education and Sustainability. Fund structured as semi-liquid, interest-paying ELTIF targeting 2-3% annual dividend.
• IMDflagshipStrategic or Co-development Partner · 15 May 2023Joint Venture Asset Management Program with IMD business school - a two-day executive education program launched in August 2023. Program focuses on shaping the future of Venture Asset Management with deep learning content for participants.
• Swiss Ventures GroupcoreOthersSerpentine Ventures AG is a fully owned subsidiary of Swiss Ventures Group AG. Part of integrated ecosystem including BV4 (venture intelligence), CodeLaw (legal services), GetGoing (operational support), and Swiss Startup Factory (venture studio).

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Speedinvest: Pan-European early-stage VC with multi-fund strategy (Seed, Follow-On, Sector funds) and similar stage focus. Comparable as a multi-manager European VC platform, though significantly larger in AUM and check size.
• Earlybird Venture Capital: European early-stage VC operating multiple sector- and stage-specific funds from Berlin. Highly comparable multi-fund manager model with both early-stage and growth funds, similar European geographic focus.
• btov Partners: European early-stage VC managing multiple specialized funds across Digital, Industrial Tech, and Health. Directly comparable multi-fund platform model and similar check sizes targeting pre-seed through Series A.
• VI Partners: Swiss early-stage VC with FINMA-equivalent regulatory standing and multi-fund structure focused on Swiss tech ventures. Direct comparable as a domestic Swiss VC peer with similar regulatory positioning.
• B Capital Group: Global multi-stage VC operating multiple sector- and stage-specific funds with FINMA-style regulated structures in select jurisdictions. Comparable as a multi-manager VC platform serving institutional LPs.

Broad incumbents

• HV Capital: Long-established German/European VC with multiple funds spanning seed to growth. Comparable multi-manager platform operating in overlapping geographies with broader stage range.
• Swisscom Ventures: Corporate venture arm of Swiss telecom incumbent investing across multiple sectors in Switzerland and Europe. Comparable as a Swiss institutional VC participant, though structurally backed by the parent telecom operator.

Others

• Redstone: Strategic partner of Serpentine that operates the Redstone Global Ventures Portfolio (ELTIF structure) integrating Serpentine's Diabetes Fund. Directly adjacent as a fund-of-funds platform that distributes Serpentine's product through Swiss banks.

Regional players

• Investiere: Swiss venture platform enabling access to startup investments for professional and retail clients, FINMA-regulated. Comparable as a Swiss-regulated investment platform offering venture exposure to qualified investors.

Peers

• Creathor Ventures: European early-stage VC managing multiple sector funds from Switzerland/Germany with FINMA-regulated structure. Directly comparable multi-fund platform with similar European footprint and stage focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments73 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Serpentine Ventures